Clinical trial
A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
NCT00203008 is registered in ClinicalTrials.gov with Teva Branded Pharmaceutical Products R&D, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- September 30, 2003
- Enrollment
- 2,106 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
malignant melanoma, parkinson's disease